Lactiplantibacillus plantarum LP02 (LMG P-21020) (formerly Lactobacillus plantarum)
Allergy & Immunology
Respiratory/ Immune health
May support a healthy response to respiratory infections [in vitro]
Single strain
Blend
Finished dosage form
a) Visciglia A. et al. Probiotics: a potential therapeutic strategy in respiratory infections. Poster from the 12th Probiotics, Prebiotics & New Foods, Nutraceutical and Botanicals for Nutrition & Human and Microbiota Health, held in Rome on 12-14 September 2021
For information on blends containing LP02, see the following Blends and Products pages:
- BIFIMMUNE®
- BIFIVIR®
- PROBIAL® Vision Dry
- LP02 + LF10
Gastroenterology
GUT DYSBIOSIS
Supports broad anti-pathogenic activity [in vitro]
Single strain
Blend
Finished dosage form
a) Mogna L. et al. Assessment of the In Vitro Inhibitory Activity of Specific Probiotic Bacteria Against Different Escherichia coli strains. J. Clin. Gastroenterol. 2012;46 Suppl.S29-32. Doi: 10.1097/MCG.0b013e31826852b7
b) Deidda F, et al. How Probiotics may Kill Harmful Bacteria: The in vitro Activity against Some Haemolytic Strains. J Prob Health, 2020. Vol. 8 Iss.2 No: 216. DOI: 10.35248/2329-8901.20.8.216
For information on blends containing LP02, see the Blends and Products pages listed above.
Gastroenterology
DETOXIFICATION/BIOSEQUESTRATION
May support healthy detoxification processes [in vitro]
May support healthy responses to environmental toxins [in vitro]
Single strain
Blend
Finished dosage form
a) Rapacioli S, et al. Innovative Perspectives on the detoxifying effects of lactobacillus probiotic strains. Poster from the 12th Probiotics, Prebiotics & New Foods, Nutraceutical and Botanicals for Nutrition & Human and Microbiota Health, held in Rome on 12-14 September 2021.
For information on blends containing LP02, see the Blends and Products pages listed above.
Neurology
Neurotransmitter synthesis
Supports production of GABA neurotransmitter [in vitro]
Single strain
a) De Prisco A. et al. Strain-specific Production of GABA by Lactobacilli and Bifidobacteria Probiotics. Poster from the 15th International Scientific Conference on Probiotics, Prebiotics, Gut Microbiota and Health – IPC2022, held in Bratislava on 27-30 June 2022.
For information on blends containing LP02, see the Blends and Products pages listed above.
Urology
URINARY TRACT HEALTH
Inhibits the growth of some common urinary tract pathogens [in vitro]
Single strain
Blend
Finished dosage form
a) Mogna L. et al. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains. J Clin Gastroenterol. 2012; 46 Suppl:S29-32. DOI: 10.35248/2329-8901.20.8.216
b) Deidda F, et al. How Probiotics may Kill Harmful Bacteria: The in vitro Activity against Some Haemolytic Strains. J Prob Health, 2020. Vol. 8 Iss.2 No: 216. DOI: 10.35248/2329-8901.20.8.216
For information on blends containing LP02, see the Blends and Products pages listed above.
